The Covid-19 pandemic has accelerated the need for remote care and patient monitoring that goes beyond the four walls of a healthcare provider. In a webinar on remote monitoring of chronic conditions, the conversation will explore how OmnySense, a medical device manufacturer in the area of home-health tracking, is using BioT’s connected care platform to support home care and remote patient monitoring. The combined system enables the connection of patients to caregivers by enhancing telemedicine calls, spotting warning signs earlier, triggering timely interventions, and reducing the need for hospitalization.
The webinar is scheduled for July 21 at 1 PM ET.
In this webinar you will learn:
- How IoMT platforms enable healthcare providers, caregivers and medtech companies to provide a personalized and full continuum of care, even at home, with the purpose of extending and improving the quality of life
- How, with the help of a connected care platform, caregivers and medical device companies can optimize their resources and workflows, gain meaningful insights from direct engagement with patients, and introduce new business models
- How OmnySense and BioT are introducing a regulated home care medical monitoring platform to enable caregivers and healthcare providers to treat their patients remotely
OmnySense is developing a multi-parameter medical device for home check-ups, seamlessly integrated into OmnySense’s cloud-based telehealth system for remote health tracking, powered by BioT.
BioT is an easy-to-integrate cloud-based platform designed to instantly connect between medical devices, patients, caregivers and data, to ensure a seamless continuum of care.
The webinar speakers are:
Daniel Adler, CEO and Co-founder, BioT
With over 20 years of extensive experience in the IT and IoT fields, Daniel now uses his deep understanding of connectivity to build cloud solutions for medical IoT devices. As the CEO at BioT, he manages the teams that develop cloud-based connectivity and connected care solutions for medical device and pharma companies.
Previously, he managed the automotive business unit at Valens, a leading semiconductor company in the area of high-speed connectivity. Prior to Valens, Daniel was VP Sales and Business Development at 3i-MIND. He also served as Director of Business Development and Strategic Accounts at NICE Systems (Symbol: NICE), in charge of worldwide key accounts. Daniel holds a B.Sc. in Computers from the Technion Israel Institute of Technology.
Ian Solomon, Co-founder and CTO, OmnySense
Ian is a serial entrepreneur in the medical device and drug delivery fields. Prior to co-founding OmnySense, he co-founded TimeStamp, which developed a connected solution for monitoring drug adherence, especially for inhalers. Previously, he was a co-founder of electronic patch-pump company SteadyMed, which was sold to United Therapeutics for $216 million.
Before his involvement in the medical world, Ian worked for over 20 years in information systems and communications in a range of technical and marketing positions. Ian holds a BSc. in Physics from Sussex University, UK.
To attend the webinar, please fill out the form below:
By filling out this form you are opting in to receive communications from MedCity News and its partners.
Photo: chombosan, Getty Images
This blog is for information purposes only. The content is not intended as medical advice, diagnosis, or treatment. Should you have a medical or dermatological problem, please consult with your physician. None of the information or recommendations on this website should be interpreted as medical advice.
All product reviews, recommendations, and references are based on the author’s personal experience and impressions using the products. All views and opinions are the author’s own.
This blog post may contain affiliate links. An affiliate link means we may earn a commission if you click on a link and make a purchase, without any extra cost to you.
Please see our Disclaimer for more information.